Hypertrophic genital herpes simplex due to HSV 2 sensitive to maximum dose of oral aciclovir-Reference-Cited by-同舟云学术

Hypertrophic genital herpes simplex due to HSV 2 sensitive to maximum dose of oral aciclovir

Published:2022-10-20 Issue:1 Volume:48 Page:43-44
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:

Author:

Folch Hugo¹^ORCID,Jahr Catalina¹^ORCID,Giacaman Paula²,Zuñiga Priscila¹,Del Pino Marcelo²

Affiliation:

1. Department of Dermatology, Hospital Clínico Universidad de Chile , Santiago , Chile

2. Department of Dermatology, Hospital San José, Santiago, Chile

Abstract

In patients who are HIV-positive, genital herpes simplex virus (HSV) infections can present with atypical clinical presentations, representing a diagnostic challenge. Hypertrophic herpes simplex has been classified as a clinical presentation that generally tends to be resistant to treatment with aciclovir. We present a case of hypertrophic HSV due to HSV Type 2, which was sensitive to maximum doses of oral aciclovir.

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://academic.oup.com/ced/advance-article-pdf/doi/10.1093/ced/llac014/48622888/llac014.pdf

Reference6 articles.

1. Rapid host immune response and viral dynamics in herpes simplex virus-2 infection;Schiffer;Nat Med,2013

2. Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study;Leeyaphan;Int J Infect Dis,2015

3. Atypical presentations of genital herpes simplex virus in HIV-1 and HIV-2 effectively treated by imiquimod;McKendry;Int J STD AIDS,2015

4. Atypical presentation of herpes simplex virus type 2 infection refractory to treatment with aciclovir in 2 hematologic patients;Nieto Rodríguez;Actas Dermosifiliogr (Engl Ed),2019